Category Archives: Cancer and Aging

Breast Cancer Breakthroughs Reported In Oncotarget

Oncotarget is known for being one of the most innovative journals in the biomedical community. Publishing twice each week, Oncotarget brings the most recent, cutting-edge work in the field of oncology to the attention of the whole medical community.

Oncology is one of the most research-intensive fields within all of medicine. Cancer touches almost every individual. Everyone has a family member, co-worker or friend who has been impacted by this terrible disease. Oncologists study and treat cancer. They are constantly on the lookout for any improvements available for their patients. Learn more about Oncotarget at

On November 15, 2017, Oncotarget broke news that an aggressive type of breast cancer cell responds to hormone therapy. This is great news for women with the fastest spreading and most dangerous forms of this disease.

Oncotarget was proud to go to publication with this important news featured on the cover. The research was conducted at the famed Mayo Clinic. The team there found that since these aggressive cancer cells lack a type of estrogen receptor. Although it is still early, this finding opens up potential pathways for research in animal models, and eventually in humans.

Recently, Oncotarget has also been able to award grants to four researchers from around the world. They include scholars at the University of Torino in Italy, the National Institute of Immunology in India and Aligarh Muslim University, also in India. Follow Oncotarget on Linkedin.

These grants took the form of travel sponsorship. Oncotarget’s sponsorship allowed these researchers to present their innovative work at the Frontiers in Cancer Science 2017 conference in Singapore. Oncotarget is committed to aiding the spread of knowledge to facilitate advances in cancer treatment. They continue to foster advances and the march towards a cure, both through publishing research and making live presentations possible.

Learn more:

Mikhail Blagosklonny’s work in anti-aging research

Mikhail Blagosklonny is an oncology professor that works at the Roswell Cancer Institute. He is a scientist that studies Cancer and Aging. He has had a massive education in the field of medicine. He attended the Pavlov State Medicine University in Petersburg. He was able to earn an MD in Internal Medicine at the University.

According to Research Gate, Mikhail furthered his studies to Ph.D. in the field of Cardiology and Experimental Medicine. He studied at the same school. Mikhail’s experience and research saw him become an associate professor of medicine at the Institute of New York Medical College in the year 2002. The college is located in Valhalla, New York.

Mikhail Blagosklonny joined Roswell Park as the Professor of Oncology in the year 2007. He has shown lots of experience and skills in his work. He has gained a massive experience in his work and has managed to become an excellent professor.

He continues to research in other fields such as biology that deal with gaining. He has led several successful research work at the institute. He is known to have pioneered research in cancer, anti-aging drugs, and therapies that influence the presence of anti-aging drug cells.

Dr. Mikhail has shown a tremendous interest in anti-aging. He has sought to create a possibility of using healthy cells from human beings and finding their causes of cancer. He has done deep research in cancer therapy. His research has seen him become famous for his work in TOR signaling and aging.

He searches for the relationship between cancer drugs and extending the lifespan of individuals. Throughout his various activities, he has published several articles about his studies. He is known as the author of several academic journals today.

Oncotarget is an example of a Dr. Mikhail Blagosklonny’s publication that was published in 2010. The journal was able to open a new access and new look in oncology and cancer research. It focused on new methods and techniques of innovative therapies. Mikhail Blagosklonny is also known as the chief editor of a popular journal called the Aging Cell. He discusses his findings in the field of oncology in the journal.